228 related articles for article (PubMed ID: 30240298)
1. Routine MRI With DWI Sequences to Detect Liver Metastases in Patients With Potentially Resectable Pancreatic Ductal Carcinoma and Normal Liver CT: A Prospective Multicenter Study.
Marion-Audibert AM; Vullierme MP; Ronot M; Mabrut JY; Sauvanet A; Zins M; Cuilleron M; Sa-Cunha A; Lévy P; Rode A
AJR Am J Roentgenol; 2018 Nov; 211(5):W217-W225. PubMed ID: 30240298
[TBL] [Abstract][Full Text] [Related]
2. Improving preoperative detection of synchronous liver metastases in pancreatic cancer with combined contrast-enhanced and diffusion-weighted MRI.
Riviere DM; van Geenen EJM; van der Kolk BM; Nagtegaal ID; Radema SA; van Laarhoven CJHM; Hermans JJ
Abdom Radiol (NY); 2019 May; 44(5):1756-1765. PubMed ID: 30659309
[TBL] [Abstract][Full Text] [Related]
3. Magnetic resonance with diffusion-weighted imaging improves assessment of focal liver lesions in patients with potentially resectable pancreatic cancer on CT.
Jeon SK; Lee JM; Joo I; Lee DH; Ahn SJ; Woo H; Lee MS; Jang JY; Han JK
Eur Radiol; 2018 Aug; 28(8):3484-3493. PubMed ID: 29352379
[TBL] [Abstract][Full Text] [Related]
4. Adjunctive role of preoperative liver magnetic resonance imaging for potentially resectable pancreatic cancer.
Kim HW; Lee JC; Paik KH; Kang J; Kim YH; Yoon YS; Han HS; Kim J; Hwang JH
Surgery; 2017 Jun; 161(6):1579-1587. PubMed ID: 28237643
[TBL] [Abstract][Full Text] [Related]
5. The diagnostic advantage of EOB-MR imaging over CT in the detection of liver metastasis in patients with potentially resectable pancreatic cancer.
Ito T; Sugiura T; Okamura Y; Yamamoto Y; Ashida R; Aramaki T; Endo M; Uesaka K
Pancreatology; 2017; 17(3):451-456. PubMed ID: 28298257
[TBL] [Abstract][Full Text] [Related]
6. Incremental Role of Pancreatic Magnetic Resonance Imaging after Staging Computed Tomography to Evaluate Patients with Pancreatic Ductal Adenocarcinoma.
Kim HJ; Park MS; Lee JY; Han K; Chung YE; Choi JY; Kim MJ; Kang CM
Cancer Res Treat; 2019 Jan; 51(1):24-33. PubMed ID: 29397657
[TBL] [Abstract][Full Text] [Related]
7. Comparison of diffusion-weighted MR imaging and multidetector-row CT in the detection of liver metastases in patients operated for pancreatic cancer.
Holzapfel K; Reiser-Erkan C; Fingerle AA; Erkan M; Eiber MJ; Rummeny EJ; Friess H; Kleeff J; Gaa J
Abdom Imaging; 2011 Apr; 36(2):179-84. PubMed ID: 20563868
[TBL] [Abstract][Full Text] [Related]
8. MRI with DWI improves detection of liver metastasis and selection of surgical candidates with pancreatic cancer: a systematic review and meta-analysis.
Altmayer S; Armelin LM; Pereira JS; Carvalho LV; Tse J; Balthazar P; Francisco MZ; Watte G; Hochhegger B
Eur Radiol; 2024 Jan; 34(1):106-114. PubMed ID: 37566274
[TBL] [Abstract][Full Text] [Related]
9. Can we rely on contrast-enhanced CT to identify pancreatic ductal adenocarcinoma? A population-based study in sensitivity and factors associated with false negatives.
LeBlanc M; Kang J; Costa AF
Eur Radiol; 2023 Nov; 33(11):7656-7664. PubMed ID: 37266655
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic accuracy of contrast-enhanced diffusion-weighted MRI for liver metastases of pancreatic cancer: towards adequate staging and follow-up of pancreatic cancer - DIA-PANC study: study protocol for an international, multicenter, diagnostic trial.
Litjens G; Rivière DM; van Geenen EJM; Radema SA; Brosens LAA; Prokop M; van Laarhoven CJHM; Hermans JJ
BMC Cancer; 2020 Aug; 20(1):744. PubMed ID: 32778061
[TBL] [Abstract][Full Text] [Related]
11. Impact of F18-fluorodeoxyglycose positron emission tomography/computed tomography on the management of resectable pancreatic tumours.
Yao J; Gan G; Farlow D; Laurence JM; Hollands M; Richardson A; Pleass HC; Lam VW
ANZ J Surg; 2012 Mar; 82(3):140-4. PubMed ID: 22510123
[TBL] [Abstract][Full Text] [Related]
12. [MRI in the evaluation of peripancreatic vessel invasion and resectability of pancreatic carcinoma].
Wang DQ; Zeng MS; Jin DY; Lou WH; Ji Y; Rao SX; Shi X; Chen CZ; Li RC
Zhonghua Zhong Liu Za Zhi; 2007 Nov; 29(11):846-9. PubMed ID: 18396644
[TBL] [Abstract][Full Text] [Related]
13. The value of liver magnetic resonance imaging in patients with findings of resectable pancreatic cancer on computed tomography.
Chew C; O'Dwyer PJ
Singapore Med J; 2016 Jun; 57(6):334-8. PubMed ID: 27353741
[TBL] [Abstract][Full Text] [Related]
14. Detection of pancreatic carcinoma and liver metastases with gadoxetic acid-enhanced MR imaging: comparison with contrast-enhanced multi-detector row CT.
Motosugi U; Ichikawa T; Morisaka H; Sou H; Muhi A; Kimura K; Sano K; Araki T
Radiology; 2011 Aug; 260(2):446-53. PubMed ID: 21693662
[TBL] [Abstract][Full Text] [Related]
15. Pathological and Radiological Splenic Vein Involvement are Predictors of Poor Prognosis and Early Liver Metastasis After Surgery in Patients with Pancreatic Adenocarcinoma of the Body and Tail.
Mizumoto T; Toyama H; Asari S; Terai S; Mukubo H; Yamashita H; Shirakawa S; Nanno Y; Ueda Y; Sofue K; Tanaka M; Kido M; Ajiki T; Fukumoto T
Ann Surg Oncol; 2018 Mar; 25(3):638-646. PubMed ID: 29264672
[TBL] [Abstract][Full Text] [Related]
16. Feasibility of Routine Application of Gadoxetic Acid-Enhanced MRI in Combination with Diffusion-Weighted MRI for the Preoperative Evaluation of Colorectal Liver Metastases.
Tanaka M; Kishi Y; Esaki M; Nara S; Miyake M; Hiraoka N; Nagino M; Shimada K
Ann Surg Oncol; 2016 Nov; 23(12):3991-3998. PubMed ID: 27357179
[TBL] [Abstract][Full Text] [Related]
17. Potentially resectable pancreatic adenocarcinoma: spiral CT assessment with surgical and pathologic correlation.
Bluemke DA; Cameron JL; Hruban RH; Pitt HA; Siegelman SS; Soyer P; Fishman EK
Radiology; 1995 Nov; 197(2):381-5. PubMed ID: 7480681
[TBL] [Abstract][Full Text] [Related]
18. Incremental value of liver MR imaging in patients with potentially curable colorectal hepatic metastasis detected at CT: a prospective comparison of diffusion-weighted imaging, gadoxetic acid-enhanced MR imaging, and a combination of both MR techniques.
Kim HJ; Lee SS; Byun JH; Kim JC; Yu CS; Park SH; Kim AY; Ha HK
Radiology; 2015 Mar; 274(3):712-22. PubMed ID: 25286324
[TBL] [Abstract][Full Text] [Related]
19. The value of positron emission tomography/computed tomography for evaluating metastatic disease in patients with pancreatic cancer.
Kim MJ; Lee KH; Lee KT; Lee JK; Ku BH; Oh CR; Heo JS; Choi SH; Choi DW
Pancreas; 2012 Aug; 41(6):897-903. PubMed ID: 22699202
[TBL] [Abstract][Full Text] [Related]
20. Preoperative evaluation of pancreatic ductal adenocarcinoma with synchronous liver metastasis: Diagnosis and assessment of unresectability.
Shi HJ; Jin C; Fu DL
World J Gastroenterol; 2016 Dec; 22(45):10024-10037. PubMed ID: 28018110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]